Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres
- 12 May 2016
- journal article
- research article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 10 (5-6) , 165-70
Abstract
Introduction: Extragonadal germ cell tumours (EGCTs) are a heterogeneous group with distinct natural history and responses to treatment modalities. We sought to evaluate characteristics and survival outcomes in men with EGCTs. Methods: We performed a retrospective analysis on a consecutive list of men diagnosed with EGCT in two Albertan cancer centres between 1990 and 2013. Demographic characteristics and outcomes, stratified by primary site, were evaluated. Results: Sixty-nine cases were identified. The median age was 29 (range 15–76) and 48 cases (70%) were non-seminomatous. Twenty-four (35%) belonged to International Germ Cell Cancer Collaborative Group (IGCCCG) favourable risk group, 14 (20%) to intermediate, and 31 (45%) to poor. Thirty (43%) had mediastinal primary (MPs); 29 were treated with first-line bleomycin, etoposide, and cisplatin (BEP). Seventeen (57%) relapses occurred, of which three patients achieved long-term survival. Seventeen (25%) had a central nervous system (CNS) primary, with eight (47%) classic germinoma. Seven (41%) received primary chemotherapy alone; 5 (29%) received primary radiotherapy alone, and 5 (29%) received both. Nineteen (28%) had a retroperitoneal primary (RPs) and received first-line chemotherapy; all but two received BEP and eight (42%) had surgical resection. Three (5%) had other or unknown primary. Five-year overall survival (OS) and disease-free survival for all patients were 56% and 44%, respectively; for MPs, 44% and 34%; for CNS primary, 76% and 53%; for RPs, 58% and 53%. Factors that correlated with decreased OS were elevated alpha fetoprotein (AFP) (pConclusions: EGCT is a rare, but important subset of GCT. Patients with EGCTs, despite aggressive treatments, still have poorer outcomes than gonadal primary.Keywords
This publication has 40 references indexed in Scilit:
- Early response to chemotherapy as an indicator for the management of germinoma-like tumors of the pineal and/or suprasellar regionsJournal of Clinical Neuroscience, 2014
- Patterns of Failure in Patients With Primary Intracranial Germinoma Treated With Neoadjuvant Chemotherapy and RadiotherapyPediatric Neurology, 2012
- Extragonadal Germ Cell Tumors: A Review With Emphasis on Pathologic Features, Clinical Prognostic Variables, and Differential Diagnostic ConsiderationsAdvances in Anatomic Pathology, 2007
- Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceAnnals of Oncology, 2005
- Outcome of Patients With Residual Germ Cell or Non-Germ Cell Malignancy After Resection of Primary Mediastinal Nonseminomatous Germ Cell CancerJournal of Clinical Oncology, 2004
- Extragonadal germ cell tumors in TaiwanCancer, 2002
- Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsAnnals of Oncology, 2002
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- Extragonadal germ cell tumors. A 14-year Toronto experienceCancer, 1994
- Do anticancer agents reach the tumor target in the human brain?Cancer Chemotherapy and Pharmacology, 1992